Trademark: 87284557
Word

Status
Registered
Status Code
705
Status Date
Tuesday, September 10, 2024
Serial Number
87284557
Registration Number
5583313
Registration Date
Tuesday, October 16, 2018
Mark Type
2
Filing Date
Thursday, December 29, 2016
Published for Opposition
Tuesday, July 31, 2018

Trademark Owner History
Compugen Ltd. - Original Registrant

Classifications
5 [ (Based on 44(e)) biological preparations featuring antibodies for the treatment of cancer, inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; anti-cancer preparations; biological preparations for the treatment of cancer inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; biopharmaceuticals for the treatment of cancer; diagnostic reagents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases ]
45 [ (Based on 44(e)) Licensing of intellectual property rights ]
42 (Based on 44(e)) (Based on Use in Commerce) Drug discovery services; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics; research and development in the field of diagnostic preparations; research in the field of pharmacogenetics; conducting clinical trials for pharmaceuticals; pharmaceutical research and development; research and development in the field of pharmaceuticals for the pharmaceutical industry; conducting early evaluations in the field of new pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; structural and functional analysis of genomes; DNA screening for scientific research purposes; biochemical research and analysis; laboratory research in the field of pharmaceuticals; research and development services in the field of immunology; medical research in the nature of computerized genetic analysis of DNA
The mark consists of a blue stylized double helix structure. The color white represents background and is not a part of the mark.
The color(s) blue is/are claimed as a feature of the mark.

Trademark Events
Mar 26, 2017
Assigned To Examiner
Apr 2, 2017
Non-Final Action Written
Jan 2, 2017
New Application Entered
Jan 10, 2017
New Application Office Supplied Data Entered
Jan 11, 2017
Notice Of Design Search Code E-Mailed
Oct 14, 2017
Suspension Letter Written
Oct 14, 2017
Letter Of Suspension E-Mailed
Oct 14, 2017
Notification Of Letter Of Suspension E-Mailed
Apr 26, 2018
Suspension Checked - To Attorney For Action
Apr 2, 2017
Non-Final Action E-Mailed
Apr 2, 2017
Notification Of Non-Final Action E-Mailed
Sep 7, 2017
Teas Response To Office Action Received
Sep 15, 2017
Assigned To Lie
Sep 20, 2017
Correspondence Received In Law Office
Sep 20, 2017
Teas/Email Correspondence Entered
May 6, 2018
Suspension Inquiry Written
May 6, 2018
Inquiry To Suspension E-Mailed
May 6, 2018
Notification Of Inquiry As To Suspension E-Mailed
Jul 31, 2018
Published For Opposition
Jun 20, 2018
Teas Response To Suspension Inquiry Received
Jun 23, 2018
Correspondence Received In Law Office
Jun 23, 2018
Teas/Email Correspondence Entered
Jun 24, 2018
Approved For Pub - Principal Register
Jul 11, 2018
Notification Of Notice Of Publication E-Mailed
Oct 16, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 27, 2024
Teas Section 8 & 15 Received
Sep 10, 2024
Case Assigned To Post Registration Paralegal
Sep 10, 2024
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Sep 10, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jul 31, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 16, 2018
Registered-Principal Register

Trademark Alertz updated from USPTO on 2030-01-24